{
  "_id": "d887a15484e174c0a69ca4f2db94e245b3fa5dc590eec60579c4ed53453d7f86",
  "feed": "market-watch",
  "title": "J&J to end COVID vaccine manufacturing deal with Emergent Biosolutions; Companies accuse each other of breaching contract",
  "text": "<p>J&amp;J provided a formal notice of termination and breach to Emergent on Monday, J&amp;J said.</p><p>The contract disclosure Monday came after Emergent BioSolutions said in a securities filing that it had sent a notice of material breach of the agreement to J&amp;J.</p><p>The contract manufacturer experienced contamination problems at its plant in Baltimore, which resulted in the destruction of key ingredients that would have amounted to roughly 400 million doses of COVID-19 vaccines from J&amp;J and AstraZeneca PLC UK:AZN, according to a recent congressional committee report.</p><p>An expanded version of this report appears on WSJ.com.</p><p>Also popular on WSJ.com:</p><p>Twitter faces probe in Texas over bots as Elon Musk threatens to pull out of deal.</p><p>The altered lives of America's school-shooting survivors.</p><p>J&amp;J to end COVID vaccine manufacturing deal with Emergent Biosolutions</p>",
  "published": "2022-06-06T21:24:00.000Z",
  "tags": [
    {
      "id": "US4781601046",
      "nexusId": "10010560",
      "name": "Johnson & Johnson",
      "offsets": [
        {
          "start": 245,
          "end": 248
        },
        {
          "start": 778,
          "end": 781
        },
        {
          "start": 0,
          "end": 3
        },
        {
          "start": 78,
          "end": 81
        },
        {
          "start": 471,
          "end": 474
        }
      ]
    }
  ]
}